nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—Tachykinin receptors bind tachykinins—TAC1—narcolepsy	0.0657	0.0824	CbGpPWpGaD
Vapreotide—SSTR5—brainstem—narcolepsy	0.0575	0.283	CbGeAlD
Vapreotide—SSTR2—brainstem—narcolepsy	0.037	0.182	CbGeAlD
Vapreotide—SSTR2—forebrain—narcolepsy	0.0357	0.176	CbGeAlD
Vapreotide—TACR1—brainstem—narcolepsy	0.0246	0.121	CbGeAlD
Vapreotide—TACR1—forebrain—narcolepsy	0.0237	0.117	CbGeAlD
Vapreotide—SSTR2—GPCRs, Other—P2RY11—narcolepsy	0.0175	0.0219	CbGpPWpGaD
Vapreotide—SSTR2—brain—narcolepsy	0.0148	0.073	CbGeAlD
Vapreotide—SSTR5—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0109	0.0137	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0109	0.0137	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.01	0.0126	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.01	0.0126	CbGpPWpGaD
Vapreotide—TACR1—brain—narcolepsy	0.00985	0.0485	CbGeAlD
Vapreotide—SSTR5—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00894	0.0112	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00852	0.0107	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00852	0.0107	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00825	0.0104	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00823	0.0103	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00801	0.0101	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00801	0.0101	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—PENK—narcolepsy	0.00797	0.01	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00791	0.00993	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00791	0.00993	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00787	0.00987	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00787	0.00987	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—P2RY11—narcolepsy	0.00774	0.00971	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0076	0.00953	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—PENK—narcolepsy	0.00735	0.00923	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0073	0.00917	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0073	0.00917	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00717	0.00899	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00717	0.00899	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00705	0.00885	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00692	0.00869	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—TRH—narcolepsy	0.00678	0.0085	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00674	0.00846	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00674	0.00846	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—PENK—narcolepsy	0.00672	0.00844	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—HCRT—narcolepsy	0.00658	0.00826	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00651	0.00817	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0065	0.00815	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—TRH—narcolepsy	0.00625	0.00785	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—PENK—narcolepsy	0.0062	0.00779	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.006	0.00753	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00588	0.00739	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00579	0.00727	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—HCRTR1—narcolepsy	0.00556	0.00698	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—HCRTR2—narcolepsy	0.00556	0.00698	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00553	0.00695	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—P2RY11—narcolepsy	0.00537	0.00674	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00535	0.00671	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00532	0.00668	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00531	0.00666	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00531	0.00666	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—HCRTR1—narcolepsy	0.00513	0.00644	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—HCRTR2—narcolepsy	0.00513	0.00644	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00512	0.00643	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—HRH3—narcolepsy	0.00501	0.00629	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—TRH—narcolepsy	0.00499	0.00626	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—P2RY11—narcolepsy	0.00496	0.00622	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00493	0.00619	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Other—HTR2A—narcolepsy	0.00493	0.00618	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00492	0.00618	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—NPS—narcolepsy	0.00492	0.00618	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00492	0.00618	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00465	0.00584	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—HRH3—narcolepsy	0.00463	0.00581	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—HCRT—narcolepsy	0.00457	0.00573	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00454	0.0057	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—NPS—narcolepsy	0.00454	0.0057	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00454	0.0057	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00446	0.0056	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00436	0.00547	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00429	0.00539	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—HCRT—narcolepsy	0.00421	0.00529	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00419	0.00526	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00419	0.00526	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—PENK—narcolepsy	0.00407	0.00511	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—HCRTR1—narcolepsy	0.00404	0.00507	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—HCRTR2—narcolepsy	0.00404	0.00507	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00399	0.005	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—P2RY11—narcolepsy	0.0039	0.0049	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00388	0.00487	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—PENK—narcolepsy	0.00376	0.00471	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00368	0.00462	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—NPS—narcolepsy	0.00362	0.00455	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—TAC1—narcolepsy	0.00362	0.00455	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00358	0.00449	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00358	0.00449	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—TRH—narcolepsy	0.00346	0.00434	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—HCRT—narcolepsy	0.00332	0.00416	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0033	0.00414	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0033	0.00414	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0033	0.00414	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00324	0.00407	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00324	0.00407	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.0032	0.00402	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—TRH—narcolepsy	0.00319	0.00401	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00314	0.00394	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00314	0.00394	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00305	0.00382	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00305	0.00382	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—P2RY11—narcolepsy	0.00304	0.00381	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—HRH3—narcolepsy	0.00303	0.00381	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—PENK—narcolepsy	0.00296	0.00371	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—HCRTR2—narcolepsy	0.0029	0.00364	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—HCRTR1—narcolepsy	0.0029	0.00364	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0029	0.00363	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HCRTR1—narcolepsy	0.00285	0.00358	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HCRTR2—narcolepsy	0.00285	0.00358	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—P2RY11—narcolepsy	0.0028	0.00352	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—HRH3—narcolepsy	0.0028	0.00352	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—P2RY11—narcolepsy	0.00276	0.00346	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HCRTR1—narcolepsy	0.00263	0.00331	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HCRTR2—narcolepsy	0.00263	0.00331	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—HCRT—narcolepsy	0.00258	0.00324	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—P2RY11—narcolepsy	0.00254	0.00319	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00252	0.00316	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—TAC1—narcolepsy	0.00251	0.00316	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—NPS—narcolepsy	0.00251	0.00316	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—TRH—narcolepsy	0.00251	0.00316	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0024	0.00301	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0024	0.00301	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—HCRT—narcolepsy	0.00238	0.00299	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HCRT—narcolepsy	0.00234	0.00294	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—TAC1—narcolepsy	0.00232	0.00291	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—NPS—narcolepsy	0.00232	0.00291	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00232	0.00291	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PENK—narcolepsy	0.0023	0.00289	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00228	0.00287	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00228	0.00287	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—P2RY11—narcolepsy	0.00221	0.00277	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—HRH3—narcolepsy	0.0022	0.00277	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00218	0.00274	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HCRT—narcolepsy	0.00216	0.00271	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00214	0.00269	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PENK—narcolepsy	0.00212	0.00266	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PENK—narcolepsy	0.00209	0.00262	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HCRTR2—narcolepsy	0.00207	0.0026	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HCRTR1—narcolepsy	0.00207	0.0026	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—P2RY11—narcolepsy	0.002	0.00251	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00199	0.00249	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—TRH—narcolepsy	0.00196	0.00245	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00195	0.00245	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PENK—narcolepsy	0.00193	0.00242	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—HCRT—narcolepsy	0.00188	0.00235	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00183	0.0023	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—NPS—narcolepsy	0.00183	0.00229	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—TAC1—narcolepsy	0.00183	0.00229	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—TRH—narcolepsy	0.0018	0.00227	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TRH—narcolepsy	0.00178	0.00223	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—HRH3—narcolepsy	0.00171	0.00215	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HCRT—narcolepsy	0.0017	0.00214	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HCRTR2—narcolepsy	0.00169	0.00212	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HCRTR1—narcolepsy	0.00169	0.00212	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PENK—narcolepsy	0.00167	0.0021	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TRH—narcolepsy	0.00164	0.00206	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—P2RY11—narcolepsy	0.00163	0.00204	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—HRH3—narcolepsy	0.00158	0.00199	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HRH3—narcolepsy	0.00156	0.00195	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HCRTR2—narcolepsy	0.00156	0.00195	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HCRTR1—narcolepsy	0.00156	0.00195	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PENK—narcolepsy	0.00152	0.0019	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—HTR2A—narcolepsy	0.00151	0.0019	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—P2RY11—narcolepsy	0.0015	0.00189	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00144	0.00181	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HRH3—narcolepsy	0.00144	0.0018	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—NPS—narcolepsy	0.00142	0.00178	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—TAC1—narcolepsy	0.00142	0.00178	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—TRH—narcolepsy	0.00142	0.00178	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—HTR2A—narcolepsy	0.0014	0.00175	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HCRT—narcolepsy	0.00138	0.00174	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00138	0.00173	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—narcolepsy	0.00135	0.0017	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—NPS—narcolepsy	0.00131	0.00165	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—TAC1—narcolepsy	0.00131	0.00165	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NPS—narcolepsy	0.00129	0.00162	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TAC1—narcolepsy	0.00129	0.00162	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TRH—narcolepsy	0.00129	0.00162	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HCRT—narcolepsy	0.00128	0.0016	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—HRH3—narcolepsy	0.00125	0.00156	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PENK—narcolepsy	0.00123	0.00155	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HCRTR2—narcolepsy	0.00122	0.00154	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HCRTR1—narcolepsy	0.00122	0.00154	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NPS—narcolepsy	0.00119	0.00149	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TAC1—narcolepsy	0.00119	0.00149	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—P2RY11—narcolepsy	0.00118	0.00148	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PENK—narcolepsy	0.00114	0.00143	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HRH3—narcolepsy	0.00113	0.00142	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—HTR2A—narcolepsy	0.0011	0.00138	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00108	0.00136	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TRH—narcolepsy	0.00105	0.00132	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—TAC1—narcolepsy	0.00103	0.0013	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—NPS—narcolepsy	0.00103	0.0013	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HCRT—narcolepsy	0.00101	0.00126	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TRH—narcolepsy	0.000968	0.00122	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NPS—narcolepsy	0.000938	0.00118	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TAC1—narcolepsy	0.000938	0.00118	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HRH3—narcolepsy	0.00092	0.00115	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PENK—narcolepsy	0.000897	0.00113	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—HTR2A—narcolepsy	0.000855	0.00107	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HRH3—narcolepsy	0.000849	0.00107	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—HTR2A—narcolepsy	0.000789	0.00099	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HTR2A—narcolepsy	0.000776	0.000974	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NPS—narcolepsy	0.000762	0.000957	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TAC1—narcolepsy	0.000762	0.000957	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TRH—narcolepsy	0.000762	0.000957	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HTR2A—narcolepsy	0.000716	0.000899	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NPS—narcolepsy	0.000704	0.000883	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TAC1—narcolepsy	0.000704	0.000883	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HRH3—narcolepsy	0.000668	0.000839	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—HTR2A—narcolepsy	0.000621	0.00078	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HTR2A—narcolepsy	0.000564	0.000708	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TAC1—narcolepsy	0.000554	0.000695	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NPS—narcolepsy	0.000554	0.000695	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HTR2A—narcolepsy	0.000459	0.000576	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HTR2A—narcolepsy	0.000423	0.000531	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HTR2A—narcolepsy	0.000333	0.000418	CbGpPWpGaD
